biotech
biotech Articles
Why do so many analysts on Wall Street have such massive upside targets for a speculative stock such as Eiger BioPharmaceuticals.
Published:
Last Updated:
Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals fits that bill despite its more than $26 billion market cap. Is it possible that some real good...
Published:
Last Updated:
Egalet saw its shares take a dive early on Tuesday after the company announced that it received a complete response letter FDA in regards to its chronic pain treatment.
Published:
Last Updated:
Akcea Therapeutics expects to price more than 9 million shares in the range of $12 to $14 apiece in an initial public offering valued up to almost $155 million.
Published:
Last Updated:
Mersana Therapeutics expects to price its 5 million shares in the range of $14 to $16 apiece in an initial public offering valued up to $92 million.
Published:
Last Updated:
Aldeyra Therapeutics saw its shares slide on Wednesday after the company said its allergic conjunctivitis drug missed the primary endpoint in this Phase 2b trial.
Published:
Last Updated:
Omeros saw its shares make a handy gain on Tuesday after the company announced that the FDA granted a Breakthrough Therapy designation for its treatment for IgA nephropathy.
Published:
Last Updated:
Coherus Biosciences saw its shares crater on Monday after the company announced that it received a complete response letter from the FDA regarding its biologics license application for a...
Published:
Last Updated:
A series of new reports from Jefferies focus on some of the top stocks in the pharmaceutical and biotech arenas. Almost all these stocks have data that could send shares measurably higher.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
In an unprecendented move, the U.S. Food and Drug administration (FDA) requested that Endo International remove its Opana ER from the market. Ultimately, the agency held concerns about abuse...
Published:
Last Updated:
In an unprecedented move, the FDA has requested that Endo International remove its opioid pain medication from the market. The agency now believes that the benefits of the drug may no longer outweigh...
Published:
Last Updated:
NewLink Genetics shares backed off early on Thursday after the company announced that it had regained the rights to its cancer treatment. Newlink shareholders are obviously not happy after missing...
Published:
Last Updated:
Shares of Novavax saw a handy gain on Wednesday after the company announced updated results from its mid-stage trial for the treatment of the respiratory syncytial virus.
Published:
Last Updated:
Calithera Biosciences shares made a decent gain early on Wednesday after the company announced that it had been granted a Fast Track Designation by the FDA.
Published:
Last Updated: